SEASPINE LLC – Trademark Portfolio

Entity Type: 16

SEASPINE LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DAYTONA and SEASPINE. The owner is based in CARLSBAD, CA.

5770 ARMADA DRIVE

CARLSBAD, CA 92008-4608

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SEASPINE
SEASPINE
Registered 2015
SEASPINE
SEASPINE
Registered 2014
DAYTONA
DAYTONA
Registered 2012
SEASPINE
SEASPINE
Registered 2002

Trademark Classifications

SEASPINE LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SEASPINE LLC have?

SEASPINE LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does SEASPINE LLC file in?

SEASPINE LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SEASPINE LLC's most well-known trademarks?

SEASPINE LLC's registered trademark portfolio includes well-known marks such as DAYTONA and SEASPINE. These are among 4 currently registered trademarks in the portfolio.

What is SEASPINE LLC's trademark registration success rate?

SEASPINE LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.